Research on third generation pill remains unpublished
BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7294.1086/b (Published 05 May 2001) Cite this as: BMJ 2001;322:1086
- Tony Sheldon
- Utrecht
A Dutch radio programme has raised further concerns about the role of unpublished, industry sponsored medical research on the risks of taking the third generation of contraceptive pill.
In its second broadcast in two months on the subject, the investigative programme Argos stated that a new study had been carried out but its results had not yet been published. The study, requested by the European Medicines Evaluation Agency, was carried out by several manufacturers of contraceptive pills, with the company Organon Netherlands acting as the “coordinating sponsor.”
The agency confirmed to the programme makers that the study was complete and that the manufacturers were free to publish the results, but the agency could not release the results …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.